Gerstner, E. R., Zhang, Z., Fink, J. R., Sorensen, G. A., L’Heureux, D., Heckel, M. L., … Barboriak, D. (2012). ACRIN 6684 assessment of tumor hypoxia in glioblastoma using 18F-fluoromisonidazole with PET and MRI. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 30). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.

Gerstner, Elizabeth Robins, Zheng Zhang, James R. Fink, Gregory A. Sorensen, Darryl L’Heureux, Martha L. Heckel, Bernadine Dunning, Mark Muzi, David A. Mankoff, and Daniel Barboriak. “ACRIN 6684 assessment of tumor hypoxia in glioblastoma using 18F-fluoromisonidazole with PET and MRI.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.

Gerstner ER, Zhang Z, Fink JR, Sorensen GA, L’Heureux D, Heckel ML, et al. ACRIN 6684 assessment of tumor hypoxia in glioblastoma using 18F-fluoromisonidazole with PET and MRI. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2012.

Gerstner, Elizabeth Robins, et al. “ACRIN 6684 assessment of tumor hypoxia in glioblastoma using 18F-fluoromisonidazole with PET and MRI.” JOURNAL OF CLINICAL ONCOLOGY, vol. 30, no. 15, AMER SOC CLINICAL ONCOLOGY, 2012.

Gerstner ER, Zhang Z, Fink JR, Sorensen GA, L’Heureux D, Heckel ML, Dunning B, Muzi M, Mankoff DA, Barboriak D. ACRIN 6684 assessment of tumor hypoxia in glioblastoma using 18F-fluoromisonidazole with PET and MRI. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2012.